Carregant...
Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma
INTRODUCTION: Hyperprogression, characterized by a rapid acceleration in tumor growth, is a novel pattern of progression recently described in patients treated with immune checkpoint inhibitors. This study aims to assess the incidence of hyperprogression in patients with advanced melanoma treated wi...
Guardat en:
| Publicat a: | Cancer Immunol Immunother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053186/ https://ncbi.nlm.nih.gov/pubmed/32929554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02716-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|